Product Information
Registration Status: ActiveSIN13670P
VIVAXIM VACCINE is approved to be sold in Singapore with effective from 2009-08-07. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN13670P.
This product contains Hepatitis A Virus (Gbm Strain) 160 i.u./0.5ml,Inactivated 25mcg/0.5ml, and Salmonella Typii Vi Polysaccharide (Ty2 Strain) in the form of SUSPENSION, STERILE. It is approved for INTRAMUSCULAR use.
This product is manufactured by SANOFI PASTEUR SA
SANOFI PASTEUR SA in FRANCE.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Poliovirus type 1 antigen is a suspension of poliovirus Type 1 (Mahoney) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 1. The vaccine contains purified and inactivated poliovirus type 1 that were grown from a continuous line of monkey kidney cells.
Active Ingredient/Synonyms
Inactivated poliomyelitis vaccine (V.C.O.) type 1 Mahoney | Inactivated poliovirus type I | poliovirus vaccine inactivated, type 1 (Mahoney) | Poliovirus type 1 antigen (formaldehyde inactivated) |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.